Research output per year
Research output per year
Fingerprint
Dive into the research topics where Kevin Winthrop is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Reply to Woodie et al, “Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX”
Torres, T., Blauvelt, A., Strober, B., van de Kerkhof, P., Eakin, G. S., Winthrop, K. & Gelfand, J. M., Jul 1 2026, In: Journal of the American Academy of Dermatology. 95, 1, p. e71-e72Research output: Contribution to journal › Letter › peer-review
1 Link opens in a new tab Scopus citations -
Development of the novel nontuberculous mycobacterial pulmonary disease symptoms scale (NTM-SS)
Henkle, E., Dieckmann, N. F., Franklin, H., Cella, D., Megson, G., Daley, C. L., Flume, P. A., McShane, P. J., Winthrop, K. L. & Quittner, A. L., Jun 1 2026, In: Quality of Life Research. 35, 6, 133.Research output: Contribution to journal › Article › peer-review
-
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis
Konzett, V., Laskou, F., Smolen, J. S., Edwards, C. J., Aletaha, D., van der Heijde, D., Winthrop, K. L., Takeuchi, T., Caporali, R., Verschueren, P., Pope, J. E., Hyrich, K. L., de Souza, S., Stamm, T. A., Primdahl, J., Schoones, J. W., Landewé, R. B. M. & Kerschbaumer, A., Jun 1 2026, In: Annals of the rheumatic diseases. 85, 6, p. 1039-1054 16 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
Smolen, J. S., Edwards, C. J., Konzett, V., Laskou, F., Aletaha, D., Caporali, R., Dörner, T., Hyrich, K. L., Mateus, E., Pope, J. E., Primdahl, J., de Souza, S., Stamm, T., Takeuchi, T., van der Heijde, D., Verschueren, P., Winthrop, K. L., Alvaro-Gracia, J. M., Askling, J. & Bathon, J. & 30 others, , Jun 1 2026, In: Annals of the rheumatic diseases. 85, 6, p. 991-1009 19 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Link opens in a new tab Scopus citations -
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis
Laskou, F., Konzett, V., Smolen, J. S., Edwards, C. J., Aletaha, D., van der Heijde, D., Winthrop, K. L., Takeuchi, T., Caporali, R., Verschueren, P., Pope, J. E., Hyrich, K., de Souza, S., Stamm, T. A., Primdahl, J., Schoones, J. W., Landewé, R. B. M. & Kerschbaumer, A., Jun 1 2026, In: Annals of the rheumatic diseases. 85, 6, p. 1055-1072 18 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations